Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women
Natalie A Bello1, Eliza C Miller1, Kirsten Lawrence Cleary1
1Columbia University Irving Medical Center, New York, New York (N.A.B., E.C.M., K.L.C., R.W.).
Insights
Cardiovascular disease and stroke are major health concerns for women. This article explores female-specific risk factors and precision medicine strategies for prevention, including genetic testing insights.
Area of Science:
- Cardiology
- Genetics
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in US women.
- Stroke ranks as the third leading cause of death for women.
- Understanding female sex-specific risk factors is crucial for effective prevention.
Observation:
- A case scenario illustrates female cardiovascular risk factors throughout life.
- Precision medicine offers a tailored approach to managing these risks.
- Recent advancements include genetic testing and polygenic risk scores.
Findings:
- Female sex-specific risk factors for cardiovascular disease and stroke are examined.
- A precision medicine framework for risk factor modification and primary prevention is detailed.
- The utility of genetic testing and polygenic risk scores in predicting cardiovascular events is updated.
Implications:
- This approach enhances primary prevention strategies for women's cardiovascular health.
- Personalized risk assessment using genetic data can improve stroke and CVD prediction.
- Integrating genetic insights into clinical practice can optimize cardiovascular care for women.
Abstract:
Cardiovascular disease is the leading cause of death among women in the United States, and stroke is third. This article uses a case scenario to examine female sex-specific cardiovascular risk factors across the lifespan and describes a precision medicine-based approach to risk factor modification and primary prevention. It also presents recent updates to the role of genetic testing and polygenic risk scores for the prediction of stroke and cardiovascular disease.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Peripheral Artery Disease III: Interprofessional Care

